The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Pharmaceuticals and the Developing World
Open accessAbstract
Pharmaceuticals have greatly improved health in developing countries, but many people in developing countries do not obtain even inexpensive pharmaceuticals and little pharmaceutical R&D is oriented toward products needed by developing countries, such as a malaria vaccine. Access to existing products could be improved by facilitating differential pricing, for example by subsidizing donation programs, and reforming health care delivery. R&D incentives could be improved if rich countries or international organization committed to purchase needed products when they are developed and make them available to the poor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bulletin of the World Health Organization
van der Sande, M. A. B., Walraven, G. E. L., Milligan, P. J., BANYA, W. A. S., CEESAY, S. M., Nyan, O. A., & McAdam, K. P. W. J. (2001) · Bulletin of the World Health Organization · Cited by 7,097
(1996) · Cited by 6,884
The Changing Relation between Mortality and level of Economic Development
Preston, S. H. (1975) · Population Studies · doi:10.1080/00324728.1975.10410201 · Cited by 1,673
Intussusception among Infants Given an Oral Rotavirus Vaccine
Murphy, T. V., Gargiullo, P. M., Massoudi, M. S., Nelson, D. B., Jumaan, A. O., Okoro, C. A., Zanardi, L. R., Setia, S., Fair, E., LeBaron, C. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102223440804 · Cited by 973
Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry
Acemoglu, D., & Linn, J. (2004) · The Quarterly Journal of Economics · doi:10.1162/0033553041502144 · Cited by 967
Friedman, M., Latham, M. C., Peacock, M., Chitester, R., Wilson, E., & Friedman, R. D. (1980) · Cited by 897
The Role of Wages and Auditing during a Crackdown on Corruption in the City of Buenos Aires
Di Tella, R., & Schargrodsky, E. (2003) · The Journal of Law and Economics · doi:10.1086/345578 · Cited by 620
New England Journal of Medicine
(2010) · Wilderness & Environmental Medicine · doi:10.1016/j.wem.2010.09.014 · Cited by 602
Ammassari, A., Murri, R., Pezzotti, P., Trotta, M. P., Ravasio, L., De Longis, P., Caputo, S. L., Narciso, P., Pauluzzi, S., Carosi, G., et al. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200112150-00006 · Cited by 473
Confronting AIDS : public priorities in a global epidemic
Ainsworth, M. (1997) · Cited by 432
Cited by
Cutler, D., Deaton, A., & Lleras-Muney, A. (2006) · Journal of Economic Perspectives · doi:10.1257/jep.20.3.97 · Cited by 1,555
The future of cystic fibrosis care: a global perspective
Bell, S. C., Mall, M. A., Gutierrez, H., Macek, M., Madge, S., Davies, J. C., Burgel, P.-R., Tullis, E., Castaños, C., Castellani, C., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30337-6 · Cited by 974
Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry
Acemoglu, D., & Linn, J. (2004) · The Quarterly Journal of Economics · doi:10.1162/0033553041502144 · Cited by 967
INNOVATION AND COMPETITIVE PRESSURE*
VIVES, X. (2008) · The Journal of Industrial Economics · doi:10.1111/j.1467-6451.2008.00356.x · Cited by 674
Compulsory Licensing: Evidence from the Trading with the Enemy Act
Moser, P., & Voena, A. (2012) · American Economic Review · doi:10.1257/aer.102.1.396 · Cited by 527
Metadata
- Authors
- Kremer, M.
- Venue
- Journal of Economic Perspectives
- Publisher
- American Economic Association
- Published
- 2002-11-01
- Volume
- 16
- Issue
- 4
- Pages
- 67-90
- ISSN
- 0895-3309 (ISSN-L)
- OpenAlex
- W2143906613
- Cited by
- 322
- References
- 28
- FWCI
- 30.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmaceuticals and the Developing World. https://app.cochat.ai/papers/10.1257/089533002320950984
- The paper
- Kremer, M. (2002). Pharmaceuticals and the Developing World. Journal of Economic Perspectives. https://doi.org/10.1257/089533002320950984
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.